Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Vibativ
Telavancin is a lipoglycopeptide antibiotic used to treat complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It works by inhibiting bacterial cell wall synthesis and disrupting cell membrane integrity.
Treatment of complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
Outcome:
Increased risk of bleeding
Mechanism:
Telavancin can interfere with vitamin K-dependent clotting factors.
Outcome:
Decreased telavancin absorption
Mechanism:
Chelation or binding of telavancin.
Outcome:
Potential for increased bleeding risk
Mechanism:
Additive effects on platelet function.
Most likely new formulation: Liposomal telavancin for improved tissue penetration and reduced nephrotoxicity (2026, 60% confidence)
Based on current usage trends and emerging resistance patterns, there is a 70% likelihood that telavancin will retain its current FDA approval status for the next 5 years.
Antibacterial, Lipoglycopeptide
Lipoglycopeptide